IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved equally high rates of tumor control with no differences in patient-reported quality of life, according to a first-of-its-kind Phase III clinical trial comparing the two technologies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup